The 2nd DNA Process Development & Manufacturing Summit: Accelerating Innovative Advanced Therapies with Revolutionary Plasmid & Enzymatic DNA.
View the Event Agenda here: https://ter.li/c1cu6w
With the plasmid DNA manufacturing market set to rise to $39.3Bn by 2033, and the demand for advanced therapies continuing to surge as gene therapy reaches new heights and DNA vaccines promise to transform outbreak response, there has never been a more crucial time to revolutionize the production of high-quality DNA as a starting material and API.
The 2nd DNA Process Development & Manufacturing Summit 2025 returns as the world’s only industry-dedicated technical forum focused on optimizing process development for plasmid and cell-free DNA, adhering to regulatory requirements to streamline IND approvals for advanced therapies, and developing scalable, efficient manufacturing solutions.
Industry experts from the likes of Pfizer, Sanofi, Novartis, Beam Therapeutics, Moderna, Merck and Chroma Medicine are uniting to share innovations in plasmid design, advances off-the-shelf lysis equipment and purification techniques, and strategies to support timely, cost-efficient large-scale DNA production.
Find out more: https://ter.li/c1cu6w
Join us there: https://ter.li/w557pg
Event Name: 2nd DNA Process Development & Manufacturing Summit
Event Venue: The Hyatt Regency, 1 Ave de Lafayette, Boston, MA 02111, United States
Event Date: March 26-27, 2025
Event website link:
Event Organizer Name: Hanson Wade Group
Communication number (with country & area code): UK: +44 (0)20 3141 8700 |
US: +1 617 455 4188
Email ID: info@hansonwade.com
Social Media Links: https://www.linkedin.com/company/hanson-wade-group/posts/?feedView=all
